TG Therapeutics Inc

TGTX

Market Cap$2.16B

Close$

Compare TG Therapeutics

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
TG Therapeutics Inc	165.4	0%	8%	14	0.6
Market Avg	59	1.3%	30%	-	1
Healthcare Avg	64.4	1.34%	15%	-	0.9

$16.18

Current Fair Value

15.8% upside

Undervalued by 15.8% based on the discounted cash flow analysis.

Share Statistics

Market cap	$2.16 Billion
Enterprise Value	$2.04 Billion
Dividend Yield	$0.0 (0.0%)
Earnings per Share	$0.09
Beta	1.41
Outstanding Shares	154,420,772
Avg 30 Day Volume	2,439,297

Return

Return on Equity	-
Return on Assets	-
Return on Invested Capital	-

Valuation & Multiples

P/E Ratio	165.39
PEG	-224.92
Price to Sales	13.98
Price to Book Ratio	13.98
Enterprise Value to Revenue	8.74
Enterprise Value to EBIT	99.01
Enterprise Value to Net Income	156
Total Debt to Enterprise	0.05
Debt to Equity	0.62

Revenue Sources

No data

ESG Score

No data

About TG Therapeutics Inc

CEO: Michael Weiss